|
ECM
component |
GeneID |
Symbol |
Name |
Fold
variation |
Tissular
fraction* |
ECM role |
|
Structural proteins |
||||||
|
|
COL1A1 |
collagen,
type I, alpha 1 |
7.18 |
SVF |
proper matrix |
|
|
|
COL1A2 |
collagen,
type I, alpha 2 |
6.64 |
SVF |
proper matrix |
|
|
|
ELN |
elastin (supravalvular aortic stenosis, Williams-Beuren
syndrome) |
3.64 |
SVF |
proper matrix |
|
|
|
COL6A3 |
collagen,
type VI, alpha 3 |
3.28 |
— |
proper matrix |
|
|
|
EMILIN2 |
elastin microfibril interfacer
2 |
2.6 |
SVF |
proper matrix |
|
|
|
COL6A2 |
collagen,
type VI, alpha 2 |
2.24 |
SVF |
cell matrix adhesion |
|
|
|
COL6A1 |
collagen,
type VI, alpha 1 |
1.93* |
SVF* |
cell matrix adhesion |
|
|
|
EMILIN1 |
elastin microfibril interfacer
1 |
1.38 |
SVF |
proper matrix |
|
|
|
COL14A1 |
collagen,
type XIV, alpha 1 (undulin) |
1.36 |
— |
cell matrix adhesion |
|
|
|
COL5A3 |
collagen,
type V, alpha 3 |
1.28 |
Adipocyte |
proper matrix |
|
|
|
COL11A2 |
collagen,
type XI, alpha 2 |
0.78 |
SVF |
proper matrix |
|
|
|
COL15A1 |
collagen,
type XV, alpha 1 |
0.77 |
SVF |
proper matrix |
|
|
|
COL2A1 |
collagen,
type II, alpha 1 (primary osteoarthritis, spondyloepiphyseal
dysplasia, congenital) |
0.76 |
— |
proper matrix |
|
|
|
COL4A1 |
collagen,
type IV, alpha 1 |
0.75 |
SVF** |
proper matrix |
|
|
|
COL24A1 |
collagen,
type XXIV, alpha 1 |
0.72 |
SVF |
proper matrix |
|
|
|
COL21A1 |
collagen,
type XXI, alpha 1 |
0.72 |
SVF |
proper matrix |
|
|
Glycoproteins |
||||||
|
|
SIGLEC1 |
sialic acid binding Ig-like lectin 1, sialoadhesin |
4.13 |
SVF |
cell cell
adhesion |
|
|
|
THBS2 |
thrombospondin 2 |
3.49 |
SVF |
cell matrix adhesion |
|
|
|
TNXB |
tenascin XB |
2.46 |
SVF |
cell matrix adhesion |
|
|
|
LGALS3BP |
lectin, galactoside-binding, soluble,
3 binding protein |
2.26 |
Adipocyte |
cell cell
adhesion |
|
|
|
POSTN |
periostin, osteoblast specific factor |
2.14 |
SVF |
cell matrix adhesion |
|
|
|
CLEC3B |
C-type lectin domain family 3, member B |
2.06 |
SVF |
cell cell
adhesion |
|
|
LAMB2 |
laminin,
beta 2 (laminin S) |
2 |
— |
cell matrix adhesion |
||
|
|
THBS3 |
thrombospondin 3 |
2 |
SVF |
cell matrix adhesion |
|
|
|
OLR1 |
oxidised low density lipoprotein (lectin-like)
receptor 1 |
1.46 |
— |
cell cell
adhesion |
|
|
|
CDH7 |
cadherin 7, type 2 |
1.41 |
— |
cell cell
adhesion |
|
|
|
LMAN2L |
lectin, mannose-binding 2-like |
1.36 |
SVF |
cell cell
adhesion |
|
|
|
LAMA5 |
laminin, alpha 5 |
1.34* |
SVF** |
cell matrix adhesion |
|
|
|
ITGBL1 |
integrin, beta-like 1 (with EGF-like repeat domains) |
1.25 |
— |
cell matrix adhesion |
|
|
|
RECK |
reversion-inducing-cysteine-rich protein with kazal
motifs |
1.19 |
— |
remodeling |
|
|
|
SIGLEC6 |
sialic acid binding Ig-like lectin 6 |
0.9 |
— |
cell cell
adhesion |
|
|
|
MAG |
myelin
associated glycoprotein |
0.89 |
— |
cell matrix adhesion |
|
|
|
CDH26 |
cadherin-like 26 |
0.85 |
SVF |
cell cell
adhesion |
|
|
|
CDH18 |
cadherin 18, type 2 |
0.8 |
— |
cell cell
adhesion |
|
|
NTN1 |
netrin 1 |
0.79 |
— |
cell matrix adhesion |
||
|
|
PCDH19 |
protocadherin 19 |
0.78 |
SVF |
cell cell
adhesion |
|
|
|
LAMA3 |
laminin, alpha 3 |
0.77 |
Adipocyte |
cell matrix adhesion |
|
|
|
LAMA4 |
laminin, alpha 4 |
0.76 |
SVF |
cell matrix adhesion |
|
|
|
LAMA2 |
laminin, alpha 2 (merosin, congenital
muscular dystrophy) |
0.73 |
SVF |
cell matrix adhesion |
|
|
|
ITGAV |
integrin, alpha V (vitronectin receptor,
alpha polypeptide, antigen CD51) |
0.72* |
Adipocyte** |
cell matrix adhesion |
|
|
|
TREH |
trehalase (brush-border membrane glycoprotein) |
0.72 |
SVF |
remodeling |
|
|
|
THBS1 |
thrombospondin 1 |
0.72* |
Adipocyte** |
cell matrix adhesion |
|
|
|
ITGB4 |
integrin, beta 4 |
0.72 |
— |
cell matrix adhesion |
|
|
|
LGALS8 |
lectin, galactoside-binding, soluble,
8 (galectin 8) |
0.7 |
SVF |
cell cell
adhesion |
|
|
|
CDH13 |
cadherin 13, H-cadherin (heart) |
0.7 |
SVF |
cell cell
adhesion |
|
|
|
CDH17 |
cadherin 17, LI cadherin (liver-intestine) |
0.66 |
SVF |
cell cell
adhesion |
|
|
|
OMG |
oligodendrocyte myelin glycoprotein |
0.66 |
— |
cell matrix adhesion |
|
|
|
MUCDHL |
mucin and cadherin-like |
0.63 |
— |
cell cell
adhesion |
|
|
|
ITGB6 |
integrin, beta 6 |
0.6 |
SVF |
cell matrix adhesion |
|
|
|
NID2 |
nidogen 2 (osteonidogen) |
0.6 |
SVF |
cell matrix adhesion |
|
|
|
GP9 |
glycoprotein
IX (platelet) |
0.53 |
SVF |
cell matrix adhesion |
|
|
|
LGALS4 |
lectin, galactoside-binding, soluble,
4 (galectin 4) |
0.5 |
SVF |
cell matrix adhesion |
|
|
|
CELSR2 |
cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog,
Drosophila) |
0.5 |
SVF |
cell cell
adhesion |
|
|
|
SELL |
selectin L (lymphocyte adhesion molecule 1) |
0.31 |
SVF |
cell cell
adhesion |
|
|
|
SELE |
selectin E (endothelial adhesion molecule 1) |
0.28 |
SVF |
cell cell
adhesion |
|
|
Glycosaminoglycans and proteoglycans |
||||||
|
|
PIGT |
phosphatidylinositol glycan anchor
biosynthesis, class T |
2 |
— |
remodeling |
|
|
|
DAG1 |
dystroglycan 1 (dystrophin-associated
glycoprotein 1) |
1.93 |
SVF |
cell matrix adhesion |
|
|
|
HAPLN3 |
hyaluronan and proteoglycan link protein 3 |
1.87 |
— |
cell matrix adhesion |
|
|
|
SDC3 |
syndecan 3 (N-syndecan) |
1.59 |
SVF |
cell matrix adhesion |
|
|
|
PIGM |
phosphatidylinositol glycan anchor
biosynthesis, class M |
1.55 |
— |
remodeling |
|
|
|
SDC2 |
syndecan 2 (heparan sulfate proteoglycan 1, cell surface-associated, fibroglycan) |
1.32 |
— |
cell matrix adhesion |
|
|
|
SPOCK1 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan
(testican) 1 |
1.15 |
SVF |
proper matrix |
|
|
|
GPC3 |
glypican 3 |
0.92 |
SVF** |
cell matrix adhesion |
|
|
|
PIGL |
phosphatidylinositol glycan anchor
biosynthesis, class L |
0.91 |
— |
remodeling |
|
|
|
SPARCL1 |
SPARC-like
1 (mast9, hevin) |
0.88 |
SVF |
proper matrix |
|
|
|
PIGK |
phosphatidylinositol glycan anchor
biosynthesis, class K |
0.85 |
— |
remodeling |
|
|
|
PODN |
podocan |
0.68 |
— |
proper matrix |
|
|
|
PIGF |
phosphatidylinositol glycan anchor
biosynthesis, class F |
0.67 |
— |
remodeling |
|
|
|
SDC1 |
syndecan 1 |
0.63 |
SVF |
cell matrix adhesion |
|
|
Enzymes |
||||||
|
|
CTSG |
cathepsin G |
2.75 |
SVF |
remodeling |
|
|
|
GUSB |
glucuronidase, beta |
2.73 |
SVF |
remodeling |
|
|
|
FUCA1 |
fucosidase, alpha-L- 1, tissue |
2.62 |
SVF |
remodeling |
|
|
|
PLOD1 |
procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1 |
2.48 |
Adipocyte |
remodeling |
|
|
|
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
2.45 |
SVF |
remodeling |
|
|
|
IDUA |
iduronidase, alpha-L- |
2.3 |
— |
remodeling |
|
|
|
HS3ST2 |
heparan sulfate (glucosamine) 3-O-sulfotransferase
2 |
2.24 |
SVF |
remodeling |
|
|
|
P4HB |
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline
4-hydroxylase), beta polypeptide |
2.17 |
— |
remodeling |
|
|
|
CTSD |
cathepsin D (lysosomal aspartyl peptidase) |
2.15 |
Adipocyte |
remodeling |
|
|
|
DPP8 |
dipeptidyl-peptidase 8 |
2.14 |
— |
remodeling |
|
|
|
PLOD3 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 |
2.12 |
SVF |
remodeling |
|
|
|
MMP2 |
matrix metallopeptidase 2 (gelatinase
A, 72kDa gelatinase, 72kDa type IV collagenase) |
2.11** |
SVF** |
remodeling |
|
|
|
CD37 |
CD37 molecule |
2.04 |
SVF |
remodeling |
|
|
|
ST3GAL5 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 5 |
2.02 |
SVF |
remodeling |
|
|
|
NAGPA |
N-acetylglucosamine-1-phosphodiester
alpha-N-acetylglucosaminidase |
1.94 |
— |
remodeling |
|
|
|
CD209 |
CD209 molecule |
1.91 |
SVF |
remodeling |
|
|
|
GBGT1 |
globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 |
1.89 |
— |
remodeling |
|
|
|
IDS |
iduronate 2-sulfatase (Hunter syndrome) |
1.79 |
Adipocyte |
remodeling |
|
|
|
STT3B |
STT3,
subunit of the oligosaccharyltransferase complex,
homolog B (S. cerevisiae) |
1.78 |
— |
remodeling |
|
|
|
FLJ21865 |
endo-beta-N-acetylglucosaminidase |
1.76 |
SVF |
remodeling |
|
|
|
TPSG1 |
tryptase gamma 1 |
1.74 |
SVF |
remodeling |
|
|
|
MGAT5 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase |
1.73 |
— |
remodeling |
|
|
|
CTSF |
cathepsin F |
1.72 |
Adipocyte |
remodeling |
|
|
|
HPSE2 |
heparanase 2 |
1.72 |
Adipocyte |
remodeling |
|
|
|
BMP1 |
bone
morphogenetic protein 1 |
1.72 |
— |
remodeling |
|
|
PCOLCE |
procollagen C-endopeptidase
enhancer |
1.70 |
SVF |
remodeling |
||
|
|
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
1.68 |
SVF |
remodeling |
|
|
|
GYLTL1B |
glycosyltransferase-like 1B |
1.67 |
— |
remodeling |
|
|
|
B4GALT4 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase,
polypeptide 4 |
1.62 |
— |
remodeling |
|
|
|
HEXA |
hexosaminidase A (alpha polypeptide) |
1.62 |
SVF |
remodeling |
|
|
|
GAL3ST1 |
galactose-3-O-sulfotransferase
1 |
1.56 |
SVF |
remodeling |
|
|
|
HS3ST5 |
heparan sulfate (glucosamine) 3-O-sulfotransferase
5 |
1.49 |
SVF |
remodeling |
|
|
|
ST8SIA5 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 |
1.48 |
— |
remodeling |
|
|
|
B3GALT6 |
UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6 |
1.46 |
SVF |
remodeling |
|
|
|
MAN1B1 |
mannosidase, alpha, class 1B, member 1 |
1.45 |
— |
remodeling |
|
|
|
NANS |
N-acetylneuraminic acid synthase
(sialic acid synthase) |
1.4 |
SVF |
remodeling |
|
|
|
ADAM15 |
ADAM metallopeptidase domain 15 (metargidin) |
1.4 |
SVF |
remodeling |
|
|
|
ST6GAL1 |
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
1.33 |
SVF |
remodeling |
|
|
|
XPNPEP2 |
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound |
1.31 |
SVF |
remodeling |
|
|
|
HABP2 |
hyaluronan binding protein 2 |
1.28 |
Adipocyte |
remodeling |
|
|
|
SLC35A2 |
solute
carrier family 35 (UDP-galactose transporter), member
A2 |
1.27 |
— |
remodeling |
|
|
|
HS3ST4 |
heparan sulfate (glucosamine) 3-O-sulfotransferase
4 |
1.26 |
Adipocyte |
remodeling |
|
|
|
ADAM11 |
ADAM metallopeptidase domain 11 |
1.26 |
Adipocyte |
remodeling |
|
|
|
PIGQ |
phosphatidylinositol glycan anchor
biosynthesis, class Q |
1.26 |
SVF |
remodeling |
|
|
|
MAN2B2 |
mannosidase, alpha, class 2B, member 2 |
1.25 |
— |
remodeling |
|
|
|
POMT1 |
protein-O-mannosyltransferase 1 |
1.22 |
— |
remodeling |
|
|
|
B3GALT4 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide
4 |
1.2 |
— |
remodeling |
|
|
|
DPP9 |
dipeptidyl-peptidase 9 |
1.18 |
— |
remodeling |
|
|
|
RPN1 |
ribophorin I |
1.18 |
— |
remodeling |
|
|
|
CHST10 |
carbohydrate
sulfotransferase 10 |
1.16 |
— |
cell matrix adhesion |
|
|
|
CHST12 |
carbohydrate
(chondroitin 4) sulfotransferase
12 |
1.16 |
SVF |
remodeling |
|
|
|
NPEPL1 |
aminopeptidase-like 1 |
1.16 |
Adipocyte |
remodeling |
|
|
|
PIGB |
phosphatidylinositol glycan anchor
biosynthesis, class B |
1.15 |
Adipocyte |
remodeling |
|
|
|
ChGn |
chondroitin beta1,4 N-acetylgalactosaminyltransferase |
1.14 |
— |
remodeling |
|
|
|
ARSB |
arylsulfatase B |
1.12 |
— |
remodeling |
|
|
|
MGAT4B |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase,
isozyme B |
1.1 |
Adipocyte |
remodeling |
|
|
|
OMA1 |
OMA1
homolog, zinc metallopeptidase (S. cerevisiae) |
0.92 |
— |
remodeling |
|
|
|
CPD |
carboxypeptidase D |
0.91 |
SVF |
remodeling |
|
|
|
ADAM22 |
ADAM metallopeptidase domain 22 |
0.89 |
SVF |
remodeling |
|
|
|
PLAU |
plasminogen activator, urokinase |
0.86 |
SVF |
remodeling |
|
|
|
SLC35A3 |
solute
carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3 |
0.86 |
— |
remodeling |
|
|
|
ADAM7 |
ADAM metallopeptidase domain 7 |
0.87 |
— |
remodeling |
|
|
|
ST3GAL4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
0.85 |
— |
remodeling |
|
|
|
ADAMTS13 |
ADAM metallopeptidase with thrombospondin
type 1 motif, 13 |
0.85 |
— |
cell matrix adhesion |
|
|
|
PPP2R1A |
protein phosphatase 2 (formerly 2A), regulatory subunit A (PR
65), alpha isoform |
0.85 |
— |
remodeling |
|
|
|
B4GALT3 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase,
polypeptide 3 |
0.83 |
SVF |
remodeling |
|
|
|
TMPRSS2 |
transmembrane protease, serine 2 |
0.83 |
— |
remodeling |
|
|
|
MMP14 |
matrix metallopeptidase 14 (membrane-inserted) |
0.81 |
SVF |
remodeling |
|
|
|
SLC35D1 |
solute
carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 |
0.81 |
— |
remodeling |
|
|
|
FUT10 |
fucosyltransferase 10 (alpha (1,3) fucosyltransferase) |
0.79 |
— |
remodeling |
|
|
|
PI3 |
peptidase
inhibitor 3, skin-derived (SKALP) |
0.79 |
SVF |
remodeling |
|
|
|
ST6GALNAC5 |
ST6
(alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3) N-acetylgalactosaminide
alpha-2,6-sialyltransferase 5 |
0.78 |
SVF |
remodeling |
|
|
|
GALNACT—2 |
chondroitin sulfate GalNAcT-2 |
0.77 |
SVF |
remodeling |
|
|
|
SULF1 |
sulfatase 1 |
0.76 |
SVF |
remodeling |
|
|
|
EXTL2 |
exostoses (multiple)-like 2 |
0.76 |
SVF |
remodeling |
|
|
|
LARGE |
like-glycosyltransferase |
0.75 |
SVF |
remodeling |
|
|
|
MGAT2 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
0.74 |
SVF |
remodeling |
|
|
|
ALG6 |
asparagine-linked glycosylation 6 homolog
(S. cerevisiae, alpha-1,3-glucosyltransferase) |
0.73 |
— |
remodeling |
|
|
|
ACHE |
acetylcholinesterase (Yt blood group) |
0.72 |
— |
cell cell
adhesion |
|
|
|
HS6ST2 |
heparan sulfate 6-O-sulfotransferase 2 |
0.73 |
— |
remodeling |
|
|
|
ADAM19 |
ADAM metallopeptidase domain 19 (meltrin
beta) |
0.72 |
SVF |
remodeling |
|
|
|
MMP7 |
matrix metallopeptidase 7 (matrilysin,
uterine) |
0.73 |
SVF |
remodeling |
|
|
|
MGAT3 |
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase |
0.71 |
SVF |
remodeling |
|
|
|
MMP11 |
matrix metallopeptidase 11 (stromelysin
3) |
0.69 |
SVF |
remodeling |
|
|
|
B4GALNT1 |
beta-1,4-N-acetyl-galactosaminyl
transferase 1 |
0.68 |
SVF |
remodeling |
|
|
|
EXT2 |
exostoses (multiple) 2 |
0.67 |
— |
remodeling |
|
|
|
MMP13 |
matrix metallopeptidase 13 (collagenase
3) |
0.66 |
— |
remodeling |
|
|
|
B3GALT2 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase,
polypeptide 2 |
0.62 |
— |
remodeling |
|
|
|
ECEL1 |
endothelin converting enzyme-like 1 |
0.54 |
— |
remodeling |
|
|
|
PLAUR |
plasminogen activator, urokinase receptor |
0.53 |
SVF |
remodeling |
|
|
|
ADAMTS1 |
ADAM metallopeptidase with thrombospondin
type 1 motif, 1 |
0.43 |
SVF |
remodeling |
|
|
|
MMP15 |
matrix metallopeptidase 15 (membrane-inserted) |
0.35 |
— |
remodeling |
|
|
Other components |
||||||
|
|
CEECAM1 |
cerebral
endothelial cell adhesion molecule 1 |
2.67 |
Adipocyte |
cell cell
adhesion |
|
|
|
CD34 |
CD34
molecule |
2.2 |
SVF |
cell matrix adhesion |
|
|
|
F13A1 |
coagulation
factor XIII, A1 polypeptide |
2.03 |
SVF |
remodeling |
|
|
|
WISP2 |
WNT1
inducible signaling pathway protein 2 |
1.94 |
SVF |
cell matrix adhesion |
|
|
|
EFEMP2 |
EGF-containing
fibulin-like extracellular matrix protein 2 |
1.83 |
Adipocyte |
proper matrix |
|
|
|
ECM1 |
extracellular
matrix protein 1 |
1.68 |
SVF |
proper matrix |
|
|
|
CGN |
cingulin |
1.63 |
— |
cell cell
adhesion |
|
|
|
DCHS1 |
dachsous 1 (Drosophila) |
1.57 |
SVF |
cell matrix adhesion |
|
|
|
TMEM16G |
transmembrane protein 16G |
1.54 |
Adipocyte |
cell matrix adhesion |
|
|
|
TYRO3 |
TYRO3
protein tyrosine kinase |
1.53 |
Adipocyte |
cell matrix adhesion |
|
|
|
FSTL1 |
follistatin-like 1 |
1.32 |
SVF |
cell matrix adhesion |
|
|
|
DCBLD1 |
discoidin, CUB and LCCL domain containing 1 |
1.3 |
— |
cell cell
adhesion |
|
|
|
PGM5 |
phosphoglucomutase 5 |
1.3 |
SVF |
cell matrix adhesion |
|
|
|
CNTN5 |
contactin 5 |
1.24 |
— |
cell matrix adhesion |
|
|
|
CNTN2 |
contactin 2 (axonal) |
1.24 |
— |
cell matrix adhesion |
|
|
|
BSG |
basigin (Ok blood group) |
1.24 |
Adipocyte |
cell matrix adhesion |
|
|
|
F11R |
F11
receptor |
1.22 |
— |
cell cell
adhesion |
|
|
|
CEACAM1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
1.21 |
— |
cell matrix adhesion |
|
|
|
SPG7 |
spastic
paraplegia 7, paraplegin (pure and complicated autosomal recessive) |
1.17 |
— |
cell matrix adhesion |
|
|
|
LRRC4B |
leucine rich repeat containing 4B |
1.16 |
Adipocyte |
cell matrix adhesion |
|
|
|
VASN |
vasorin |
1.16 |
SVF |
cell matrix adhesion |
|
|
|
ADRM1 |
adhesion
regulating molecule 1 |
1.15 |
— |
cell matrix adhesion |
|
|
|
PARD6G |
par-6
partitioning defective 6 homolog gamma (C. elegans) |
1.11 |
— |
cell cell
adhesion |
|
|
|
VEZT |
vezatin, adherens junctions transmembrane protein |
0.89 |
— |
cell cell
adhesion |
|
|
|
JAM2 |
junctional adhesion molecule 2 |
0.86 |
SVF |
cell cell
adhesion |
|
|
|
CEACAM4 |
carcinoembryonic antigen-related cell adhesion molecule 4 |
0.85 |
SVF |
cell cell
adhesion |
|
|
|
FAT2 |
FAT tumor
suppressor homolog 2 (Drosophila) |
0.84 |
— |
cell matrix adhesion |
|
|
|
DCBLD2 |
discoidin, CUB and LCCL domain containing 2 |
0.84 |
— |
cell matrix adhesion |
|
|
|
CLDN7 |
claudin 7 |
0.81 |
SVF |
cell cell
adhesion |
|
|
|
GJC1 |
gap
junction protein, chi 1, 31.9kDa (connexin 31.9) |
0.8 |
SVF |
cell matrix adhesion |
|
|
|
MPZL1 |
myelin
protein zero-like 1 |
0.8 |
SVF |
cell cell
adhesion |
|
|
|
ICAM3 |
intercellular
adhesion molecule 3 |
0.8 |
— |
cell cell
adhesion |
|
|
|
CLDN12 |
claudin 12 |
0.79 |
— |
cell cell
adhesion |
|
|
|
PKHD1 |
polycystic
kidney and hepatic disease 1 (autosomal recessive) |
0.79 |
— |
cell cell
adhesion |
|
|
|
CLDN8 |
claudin 8 |
0.78 |
— |
cell matrix adhesion |
|
|
|
RELN |
reelin |
0.78 |
— |
cell cell
adhesion |
|
|
|
MATN3 |
matrilin 3 |
0.78 |
SVF |
proper matrix |
|
|
|
ASTN1 |
astrotactin 1 |
0.74 |
SVF |
cell cell
adhesion |
|
|
|
ROBO1 |
roundabout,
axon guidance receptor, homolog 1 (Drosophila) |
0.73 |
— |
cell matrix adhesion |
|
|
|
GJA1 |
gap
junction protein, alpha 1, 43kDa (connexin 43) |
0.71 |
SVF |
cell cell
adhesion |
|
|
|
PANX1 |
pannexin 1 |
0.7 |
SVF |
cell cell
adhesion |
|
|
|
ICAM1 |
intercellular
adhesion molecule 1 (CD54), human rhinovirus receptor |
0.66 |
SVF |
cell cell
adhesion |
|
|
|
F3 |
coagulation
factor III (thromboplastin, tissue factor) |
0.63 |
— |
remodeling |
|
|
|
MADCAM1 |
mucosal
vascular addressin cell adhesion molecule 1 |
0.61 |
SVF |
cell matrix adhesion |
|
|
|
AMIGO2 |
adhesion
molecule with Ig-like domain 2 |
0.59 |
SVF |
cell cell
adhesion |
|
|
|
VNN2 |
vanin 2 |
0.54 |
SVF |
cell matrix adhesion |
|
|
|
ICAM5 |
intercellular
adhesion molecule 5, telencephalin |
0.47 |
Adipocyte |
cell cell
adhesion |
|
|
|
CEACAM6 |
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific
cross reacting antigen) |
0.43 |
SVF |
cell cell
adhesion |
|
|
SVF = Stroma Vascular Fraction The indicated fold variations were measured in the cDNA microarray experiments. * Using RTqPCR,
the change in expression of these genes was confirmed in 6 independent obese
subjects before and after weight loss induced by gastric bypass. ** Using RTqPCR,
the change in expression of these genes was also confirmed in 6 independent
samples of human WAT where mature adipocytes and SVF fractions were separated
by enzymatic digestion. |
||||||